Hypoglossal Nerve Stimulation Therapy in Patients With Obstructive Sleep Apnea: Belgian Registry
Condition(s) studied
Investigational drug(s) / intervention(s)
Hypoglossal nerve stimulation Inspire system (Inspire Medical Systems Inc., USA): Hypoglossal nerve stimulation therapy
Study summary
Hypoglossal nerve stimulation (HNS) therapy (Inspire system) is intended for the treatment of patients with moderate to severe obstructive sleep apnea (OSA) who cannot be effectively treated with the first-line treatment options. Recently, the request for reimbursement of the Inspire system in Belgium was approved.
The aim is to create a multi-center registry of OSA patients that are treated with HNS (Inspire system) within routine clinical care in Belgium.
Eligibility
Primary outcome measure(s)
- Delta apnea-hypopnea index (AHI) as measured by a polysomnography — From baseline to 6, 12 and 60 months post-implantation
The AHI is an index of sleep apnea severity that encompasses the frequency of apneas (cessations in breathing) and hypopneas (reductions in airflow) per hour of sleep.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Antwerp University Hospital | Edegem | Antwerp | Recruiting |
| AZ Sint-Jan Brugge | Bruges | West-Vlaanderen | Recruiting |
More University Hospital, Antwerp trials in Belgium
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06332404 on ClinicalTrials.gov ↗ ← All trials in Belgium